Press Coverage

The True Costs of Pivotal Trials that Support FDA Approval

Article summarizes a study co-authored by ISMP Senior Scientist Tom Moore and published online in JAMA Internal Medicine that explores the median costs for pivotal clinical trials leading to FDA approval for novel drugs.

For the full text of the article, visit Medscape online


More News

In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, ISMP is emphasizing that the focus should be on identifying and fixing imperfect systems instead of unjustly blaming the individual healthcare practitioner.